VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,995 | +77.7% | 120,249 | +46.7% | 0.00% | – |
| Q4 2022 | $8,440 | -84.4% | 81,945 | -77.4% | 0.00% | – |
| Q3 2022 | $54,000 | -82.5% | 361,859 | +3.5% | 0.00% | – |
| Q2 2022 | $308,000 | +77.0% | 349,569 | +148.8% | 0.00% | – |
| Q1 2022 | $174,000 | -87.8% | 140,518 | -80.8% | 0.00% | – |
| Q4 2021 | $1,426,000 | +55.0% | 732,124 | +118.0% | 0.00% | – |
| Q3 2021 | $920,000 | +1459.3% | 335,825 | +1705.3% | 0.00% | – |
| Q2 2021 | $59,000 | -89.0% | 18,602 | -92.6% | 0.00% | – |
| Q1 2021 | $538,000 | +5877.8% | 252,494 | +1175.6% | 0.00% | – |
| Q1 2020 | $9,000 | 0.0% | 19,794 | +44.7% | 0.00% | – |
| Q4 2019 | $9,000 | -40.0% | 13,681 | -3.4% | 0.00% | – |
| Q3 2019 | $15,000 | -84.8% | 14,161 | -80.5% | 0.00% | – |
| Q2 2018 | $99,000 | -89.3% | 72,467 | -91.3% | 0.00% | – |
| Q4 2017 | $926,000 | – | 834,288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $36,943,000 | 14.76% |
| VR Adviser, LLC | 16,047,286 | $50,549,000 | 6.13% |
| COMMODORE CAPITAL LP | 3,331,315 | $10,494,000 | 3.66% |
| Ghost Tree Capital, LLC | 2,000,000 | $6,300,000 | 1.73% |
| EPIQ PARTNERS, LLC | 932,956 | $2,939,000 | 1.47% |
| SPHERA FUNDS MANAGEMENT LTD. | 4,080,673 | $12,854,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 615,547 | $1,939,000 | 0.86% |
| HighVista Strategies LLC | 308,096 | $971,000 | 0.69% |
| NEA Management Company, LLC | 16,302,596 | $51,353,000 | 0.67% |
| Nicholas Investment Partners, LP | 2,753,880 | $8,675,000 | 0.54% |